enVVeno Medical Corporation NVNO
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.37M | -3.60M | -3.85M | -3.74M | -4.54M |
| Total Depreciation and Amortization | 110.00K | 29.00K | 124.00K | 117.00K | 120.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 433.00K | 419.00K | 514.00K | 716.00K | 727.00K |
| Change in Net Operating Assets | 646.00K | -397.00K | -27.00K | -540.00K | -700.00K |
| Cash from Operations | -3.18M | -3.55M | -3.24M | -3.44M | -4.39M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.74M | 3.67M | 2.77M | 4.18M | 3.65M |
| Cash from Investing | 2.74M | 3.67M | 2.77M | 4.18M | 3.65M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 187.00K | 126.00K | -- | 782.00K | 241.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 187.00K | 126.00K | -- | 782.00K | 241.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -256.00K | 244.00K | -468.00K | 1.52M | -500.00K |